JPS5394029A - Medicac composition for oral dose - Google Patents

Medicac composition for oral dose

Info

Publication number
JPS5394029A
JPS5394029A JP208078A JP208078A JPS5394029A JP S5394029 A JPS5394029 A JP S5394029A JP 208078 A JP208078 A JP 208078A JP 208078 A JP208078 A JP 208078A JP S5394029 A JPS5394029 A JP S5394029A
Authority
JP
Japan
Prior art keywords
medicac
composition
oral dose
oral
dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP208078A
Other languages
English (en)
Inventor
Berubiru Mariisu
Meruru Furansowaazu
Kuroodo Rushieban Jiyan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sante SAS
Original Assignee
LIPHA SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LIPHA SAS filed Critical LIPHA SAS
Publication of JPS5394029A publication Critical patent/JPS5394029A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP208078A 1977-01-13 1978-01-13 Medicac composition for oral dose Pending JPS5394029A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7700810A FR2377196A1 (fr) 1977-01-13 1977-01-13 Composition medicamenteuse a usage oral

Publications (1)

Publication Number Publication Date
JPS5394029A true JPS5394029A (en) 1978-08-17

Family

ID=9185421

Family Applications (1)

Application Number Title Priority Date Filing Date
JP208078A Pending JPS5394029A (en) 1977-01-13 1978-01-13 Medicac composition for oral dose

Country Status (6)

Country Link
US (1) US4155993A (ja)
JP (1) JPS5394029A (ja)
BE (1) BE862850A (ja)
DE (1) DE2800654A1 (ja)
ES (1) ES465906A1 (ja)
FR (1) FR2377196A1 (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
FR2453639A1 (fr) * 1979-04-09 1980-11-07 Sanofi Sa Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl
FR2453641A1 (fr) * 1979-04-12 1980-11-07 Sanofi Sa Compositions therapeutiques a usage oral et a liberation programmee l'oxalate de naftidrofuryl
JPS5668609A (en) * 1979-11-07 1981-06-09 Nippon Kayaku Co Ltd Phthalazinol preparation
FR2506157A1 (fr) * 1981-05-20 1982-11-26 Lipha Preparation pharmaceutique de " naftidrofuryl " a liberation controlee
US4795327A (en) * 1984-03-26 1989-01-03 Forest Laboratories, Inc. Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
US4695464A (en) * 1984-10-09 1987-09-22 The Dow Chemical Company Sustained release dosage form based on highly plasticized cellulose ether gels
US4678516A (en) * 1984-10-09 1987-07-07 The Dow Chemical Company Sustained release dosage form based on highly plasticized cellulose ether gels
GB8521494D0 (en) * 1985-08-29 1985-10-02 Zyma Sa Controlled release tablet
JPS62103012A (ja) * 1985-10-23 1987-05-13 Eisai Co Ltd 多重顆粒
US4910082A (en) * 1986-10-10 1990-03-20 Hoechst Celanese Corp. Ultrathin polyphenylene oxide polymer films and their preparation
US4746476A (en) * 1986-10-10 1988-05-24 Hoechst Celanese Corporation Ultrathin polyphenylene oxide polymer films and their preparation
US4752470A (en) * 1986-11-24 1988-06-21 Mehta Atul M Controlled release indomethacin
JP2643222B2 (ja) * 1988-02-03 1997-08-20 エーザイ株式会社 多重層顆粒
US5175003A (en) * 1990-04-06 1992-12-29 Biosytes Usa, Inc. Dual mechanism controlled release system for drug dosage forms
US5871776A (en) * 1995-01-31 1999-02-16 Mehta; Atul M. Controlled-release nifedipine
DE19511131A1 (de) * 1995-03-27 1996-10-02 Basf Ag Mechanisch stabile feste Wirkstoffzubereitungsformen
US20060062843A1 (en) * 1996-03-25 2006-03-23 Wyeth Extended release formulation
GB9814411D0 (en) * 1998-07-03 1998-09-02 Mw Encap Limited Capsule sealing system

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2887440A (en) * 1957-08-12 1959-05-19 Dow Chemical Co Enteric coating
NL265304A (ja) 1960-05-31
FR1290661A (fr) * 1960-05-31 1962-04-13 Abbott Lab Méthode d'enrobage de comprimés
US3247066A (en) * 1962-09-12 1966-04-19 Parke Davis & Co Controlled release dosage form containing water-swellable beadlet
NL142872C (ja) * 1963-03-28
US3388041A (en) * 1964-01-27 1968-06-11 Richardson Merrell Inc High dosage sustained release tablet
US3538214A (en) * 1969-04-22 1970-11-03 Merck & Co Inc Controlled release medicinal tablets
DE2010416B2 (de) * 1970-03-05 1979-03-29 Hoechst Ag, 6000 Frankfurt Oral anwendbare Arzneiform mit Retardwirkung
GB1468172A (en) * 1973-03-28 1977-03-23 Benzon As Alfred Oral drug preparations
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform

Also Published As

Publication number Publication date
BE862850A (fr) 1978-07-12
DE2800654A1 (de) 1978-07-20
US4155993A (en) 1979-05-22
FR2377196A1 (fr) 1978-08-11
ES465906A1 (es) 1979-01-01

Similar Documents

Publication Publication Date Title
AU4084178A (en) Dental composition
JPS53113007A (en) Pharmaceutical composition
JPS53109934A (en) Pharmaceutical composition
KE3525A (en) Pharmaceutical compositions
GB2003028B (en) Pharmaceutical compositions
AU3628878A (en) Impression materials for dentistry
JPS5484022A (en) Pharmaceutical composition
JPS55111413A (en) Composition for mouthcavity
JPS5394029A (en) Medicac composition for oral dose
JPS53133637A (en) Pharmaceutical composition
JPS5449333A (en) Pharmaceutical composition
PH15193A (en) Pharmaceutical composition
GB2021409B (en) Pharmaceutical composition
GB2002229B (en) Pharmaceutical composition
GB2008403B (en) Pharmaceutical compositions
JPS5394038A (en) Pharmaceutical composition
ZA784470B (en) Pharmaceutical compositions including antithormbotic compositions
MW478A1 (en) Pharmaceutical compositions
NZ186722A (en) Therapeutic compositions containing transbroparestrol
NZ186334A (en) Oxadiazolopyrimidines:pharmaceutical compositions
JPS53101520A (en) Pharmaceutical composition
GB2008408B (en) Pharmaceutical compositions
JPS53124630A (en) Oral composition
ZA7812B (en) Pharmaceutical compositions
MY8300087A (en) Oral compositions